These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 8150755)

  • 1. Low-dosage cefepime as treatment for serious bacterial infections.
    Giamarellou H
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():123-32. PubMed ID: 8150755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-comparative, multicentre study of cefepime in the treatment of serious bacterial infections.
    Mouton Y; Chidiac C; Humbert G; Leroy J; Veyssier P; Modai J; Bertrand A; Dellamonica P; Micoud M; Stahl JP
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():133-40. PubMed ID: 8150757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-comparative study of the efficacy and tolerance of cefepime in combination with amikacin in the treatment of severe infections in patients in intensive care.
    Gouin F; Papazian L; Martin C; Albanese J; Durbec O; Domart Y; Veyssier P; Leroy J; Grès JJ; Rollin C
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():205-14. PubMed ID: 8150764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical applications of a new parenteral antibiotic in the treatment of severe bacterial infections.
    Holloway WJ; Palmer D
    Am J Med; 1996 Jun; 100(6A):52S-59S. PubMed ID: 8678098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections.
    Hoepelman AI; Kieft H; Aoun M; Kosmidis J; Strand T; Verhoef J; Gillespie SH; Riddell J; Varghese G; Meunier F
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():175-86. PubMed ID: 8150761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of cefepime (BMY 28142) to treat respiratory infections.
    Clynes N; Scully BE; Neu HC
    Diagn Microbiol Infect Dis; 1989; 12(3):257-60. PubMed ID: 2791488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefepime as treatment for osteomyelitis and other severe bacterial infections.
    Jauregui L; Matzke D; Scott M; Minns P; Hageage G
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():141-9. PubMed ID: 8150758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of urinary tract infections: selecting an appropriate broad-spectrum antibiotic for nosocomial infections.
    Sharifi R; Geckler R; Childs S
    Am J Med; 1996 Jun; 100(6A):76S-82S. PubMed ID: 8678101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter comparative study of cefepime versus broad-spectrum antibacterial therapy in moderate and severe bacterial infections.
    Badaró R; Molinar F; Seas C; Stamboulian D; Mendonça J; Massud J; Nascimento LO;
    Braz J Infect Dis; 2002 Oct; 6(5):206-18. PubMed ID: 12495602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of cefepime and ceftazidime in the treatment of community-acquired lower respiratory tract infections.
    Léophonte P; Bertrand A; Nouvet G; Muir JF; Lucht F; Delaval P; Depierre A; Hughes F; Ulmer M; Grès JJ
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():165-73. PubMed ID: 8150760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open trial of cefepime (BMY 28142) for infections in hospitalized patients.
    Oster S; Edelstein H; Cassano K; McCabe R
    Antimicrob Agents Chemother; 1990 Jun; 34(6):954-7. PubMed ID: 2203309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparative study of cefepime and cefotaxime in the treatment of acute obstetric and gynaecological infections.
    Newton ER; Yeomans ER; Pastorek JG; Soper DE; Hemsell DL
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():195-204. PubMed ID: 8150763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefepime versus cefotaxime in the treatment of lower respiratory tract infections.
    Barckow D; Schwigon CD
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():187-93. PubMed ID: 8150762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefepime.
    Cunha BA; Gill MV
    Med Clin North Am; 1995 Jul; 79(4):721-32. PubMed ID: 7791419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of cefepime in the treatment of serious bacterial infections in hospitalized adult patients.
    Sheng WH; Wang JT; Chang SC
    J Microbiol Immunol Infect; 2000 Jun; 33(2):109-14. PubMed ID: 10917881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Barradell LB; Bryson HM
    Drugs; 1994 Mar; 47(3):471-505. PubMed ID: 7514976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of cefepime and ceftazidime for treatment of skin, surgical wound, and complicated urinary tract infections in hospitalized subjects.
    Gentry LO; Rodriguez-Gomez G
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2371-4. PubMed ID: 1804010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empiric use of cefepime in the treatment of lower respiratory tract infections in children.
    Bradley JS; Arrieta A
    Pediatr Infect Dis J; 2001 Mar; 20(3):343-9. PubMed ID: 11303848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of cefepime versus ceftazidime in the treatment of severe infections.
    Huang CK; Chen YS; Lee SS; Lin WR; Tsai HC; Lin HH; Wann SR; Chen JY; Yen MY; Liu YC
    J Microbiol Immunol Infect; 2002 Sep; 35(3):159-67. PubMed ID: 12380788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.